uracil has been researched along with Cancer of Mouth in 20 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
| Excerpt | Relevance | Reference |
|---|---|---|
| "We studied the usefulness and safety of long-term administration of uracil and tegafur (UFT) after primary therapy of the malignant tumor in jaw and oral cavity regions randomized controlled trial." | 2.67 | [Multiple cooperative study of UFT-adjuvant chemotherapy for malignant tumor in the jaw and oral cavities. The Oral Surgery Malignant Tumor Research Association in Kanto Kohshinetsu District]. ( Asakura, A; Fukuda, H; Hagiwara, T; Kobayashi, A; Kotani, A; Nemoto, K; Sakamoto, H; Sunada, O; Takaku, S; Tamura, M, 1994) |
| "Tegafur-uracil treatment is a useful, effective, and well-tolerated anticancer treatment for advanced oral cancer." | 1.48 | The Impact of Metronomic Adjuvant Chemotherapy in Patients with Advanced Oral Cancer. ( Chang, DC; Chen, G; Chen, MK; Chien, SY; Hsieh, MY, 2018) |
| "Twenty patients with previously untreated squamous cell carcinoma of the oral cavity and oropharynx (T4; 8, T2; 12 patients) were treated with targeted transfemoral intra-arterial carboplatin infusion with concurrent hyperfractionated radiotherapy and the administration of tegafur/uracil (UFT)." | 1.33 | Targeted intra-arterial carboplatin chemoradiotherapy and tegafur/uracil for oral and oropharyngeal cancer. ( Ikemura, K; Imada, H; Inenaga, R; Korogi, Y; Nakamura, S; Onari, N; Oya, R; Takagi, S, 2006) |
| "In this study, 109 oral squamous cell carcinomas were investigated for the immunohistochemical expression of TS and DPD proteins." | 1.31 | Thymidylate synthase and dihydropyrimidine dehydrogenase expression in oral squamous cell carcinoma: an immunohistochemical and clinicopathologic study. ( Kawasaki, G; Mizuno, A; Yanamoto, S; Yoshitomi, I, 2002) |
| "UFT was administered orally at a dosage of 200 mg/day, 2 times a day, to patients over 80 years of age with oral cancer." | 1.31 | [5-FU concentration in the serum and the tumor tissue after administration of UFT 200 mg/day to patients over 80 years of age with oral cancer]. ( Fukuda, J; Hayatsu, M; Hoshina, H; Iida, A; Kaji, M; Miyamoto, T; Miyaura, Y; Nagashima, K; Ono, K; Takagi, R; Tsurumaki, H, 2000) |
| "A 73-year-old male with squamous cell carcinoma of the oral floor (T1N0M0), who had not consented to radical treatment was treated with UFT by oral administration alone." | 1.31 | [A case of squamous cell carcinoma of the oral floor showing a complete response to oral administration of UFT]. ( Fujisawa, A; Ikeda, H; Inokuchi, T; Kitamura, A; Nonaka, M; Ohba, S; Tobita, T; Uehara, M, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (20.00) | 18.7374 |
| 1990's | 4 (20.00) | 18.2507 |
| 2000's | 10 (50.00) | 29.6817 |
| 2010's | 2 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsieh, MY | 1 |
| Chen, G | 1 |
| Chang, DC | 1 |
| Chien, SY | 1 |
| Chen, MK | 1 |
| Yamashita, T | 1 |
| Toida, M | 1 |
| Kato, K | 1 |
| Long, NK | 1 |
| Miyazaki, Y | 1 |
| Asaka, Y | 1 |
| Hatakeyama, D | 1 |
| Yonemoto, K | 1 |
| Makita, H | 1 |
| Kato, Y | 1 |
| Shibata, T | 2 |
| Kawasaki, G | 2 |
| Yoshitomi, I | 2 |
| Yanamoto, S | 2 |
| Yamada, S | 1 |
| Kawano, T | 1 |
| Mizuno, A | 2 |
| Fujimori, S | 1 |
| Kurita, H | 2 |
| Azegami, T | 1 |
| Koike, T | 2 |
| Ohtsuka, A | 1 |
| Kobayashi, H | 2 |
| Tanaka, K | 1 |
| Kurashina, K | 2 |
| Kawano, K | 1 |
| Goto, H | 1 |
| Kanda, T | 1 |
| Yanagisawa, S | 1 |
| Miyazawa, H | 1 |
| Uehara, S | 1 |
| Oya, R | 1 |
| Takagi, S | 1 |
| Inenaga, R | 1 |
| Nakamura, S | 1 |
| Ikemura, K | 1 |
| Onari, N | 1 |
| Imada, H | 1 |
| Korogi, Y | 1 |
| Oshikawa, T | 1 |
| Okamoto, M | 1 |
| Ahmed, SU | 1 |
| Tano, T | 1 |
| Sato, M | 1 |
| Takeshima, M | 1 |
| Saitoh, M | 1 |
| Kusano, K | 1 |
| Nagayasu, H | 1 |
| Kurashige, Y | 1 |
| Malsantha, M | 1 |
| Arakawa, T | 1 |
| Takuma, T | 1 |
| Chiba, I | 1 |
| Kaku, T | 1 |
| Abiko, Y | 1 |
| Kotani, A | 1 |
| Sunada, O | 1 |
| Tamura, M | 1 |
| Takaku, S | 1 |
| Kobayashi, A | 1 |
| Asakura, A | 1 |
| Sakamoto, H | 1 |
| Nemoto, K | 1 |
| Fukuda, H | 1 |
| Hagiwara, T | 1 |
| Matsuda, A | 1 |
| Dan, A | 1 |
| Minakawa, N | 1 |
| Tregear, SJ | 1 |
| Okazaki, S | 1 |
| Sugimoto, Y | 1 |
| Sasaki, T | 1 |
| Kurokawa, H | 1 |
| Miura, K | 1 |
| Yamashita, Y | 1 |
| Tokudome, S | 1 |
| Murata, T | 1 |
| Kajiyama, M | 1 |
| Naito, Y | 1 |
| Kimura, S | 1 |
| Yoshizawa, M | 1 |
| Ohtake, K | 1 |
| Nakajima, T | 1 |
| Saku, T | 1 |
| Iida, A | 1 |
| Takagi, R | 1 |
| Hoshina, H | 1 |
| Ono, K | 1 |
| Kaji, M | 1 |
| Tsurumaki, H | 1 |
| Fukuda, J | 1 |
| Nagashima, K | 1 |
| Miyaura, Y | 1 |
| Hayatsu, M | 1 |
| Miyamoto, T | 1 |
| Ikeda, H | 1 |
| Kitamura, A | 1 |
| Uehara, M | 1 |
| Tobita, T | 1 |
| Ohba, S | 1 |
| Nonaka, M | 1 |
| Fujisawa, A | 1 |
| Inokuchi, T | 1 |
| Fabrissin, S | 1 |
| de Nardo, M | 1 |
| Nisi, C | 1 |
| Morasca, L | 1 |
| Dolfini, E | 1 |
| Franchi, G | 1 |
| Tsukuda, M | 1 |
| Yanoma, S | 1 |
| Ono, T | 1 |
| Sudo, K | 1 |
| Sawaki, S | 1 |
| Inuyama, Y | 1 |
| Tanaka, J | 1 |
| Takaoka, T | 1 |
| Hosoda, H | 1 |
| Fujii, M | 1 |
| Kohno, N | 1 |
| Richards, EG | 1 |
2 trials available for uracil and Cancer of Mouth
| Article | Year |
|---|---|
[Multiple cooperative study of UFT-adjuvant chemotherapy for malignant tumor in the jaw and oral cavities. The Oral Surgery Malignant Tumor Research Association in Kanto Kohshinetsu District].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1994 |
[Evaluation of neo-adjuvant chemotherapy for oral squamous cell carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; | 1997 |
18 other studies available for uracil and Cancer of Mouth
| Article | Year |
|---|---|
The Impact of Metronomic Adjuvant Chemotherapy in Patients with Advanced Oral Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Case-Control Studies; Chem | 2018 |
The effect of neoadjuvant therapy on the 5-fluorouracil metabolic and relative enzymes of oral squamous cell carcinoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcin | 2009 |
[Immunohistochemical and clinicopathological study of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyl transferase expression in oral cancer patients responding to UFT].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation | 2010 |
Thymidylate synthase and dihydropyrimidine dehydrogenase expression in oral squamous cell carcinoma: an immunohistochemical and clinicopathologic study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous | 2002 |
[Neoadjuvant chemotherapy with nedaplatin and UFT for oral squamous cell carcinomas].
Topics: Aged; Aged, 80 and over; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamo | 2003 |
Predictive value of immunohistochemical thymidylate synthase expression for histological response to Tegafur/Uracil (UFT) in oral squamous cell carcinoma.
Topics: Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell | 2003 |
Retrospective analysis on prognostic impact of adjuvant chemotherapy in the patients with advanced and resectable oral squamous cell carcinoma.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols | 2006 |
Targeted intra-arterial carboplatin chemoradiotherapy and tegafur/uracil for oral and oropharyngeal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carboplatin; | 2006 |
[The relationship between gene expression of Bcl-2 and Bax and the therapeutic effect in oral cancer patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; bcl-2-Associated X Protein; Gene Expression; Genes, | 2006 |
High frequency of hypermethylation of p14, p15 and p16 in oral pre-cancerous lesions associated with betel-quid chewing in Sri Lanka.
Topics: Alleles; Areca; CpG Islands; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibito | 2008 |
Nucleosides and nucleotides. 123. Synthesis of 1-(2-deoxy-2-isocyano-beta-D-arabinofuranosyl)cytosine and related nucleosides as potential antitumor agents.
Topics: Animals; Antineoplastic Agents; Cytarabine; Deoxycytidine; Drug Stability; Humans; Isocyanates; Leuk | 1993 |
Effects of the anticancer drug cocktail "UFT" on metastatic potentials of squamous cell carcinoma (O-1N) in a hamster model.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols | 1998 |
[5-FU concentration in the serum and the tumor tissue after administration of UFT 200 mg/day to patients over 80 years of age with oral cancer].
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Proto | 2000 |
[A case of squamous cell carcinoma of the oral floor showing a complete response to oral administration of UFT].
Topics: Administration, Oral; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Combinations; Huma | 2001 |
Synthesis and anticancer activity of 5-diethylaminomethyl derivatives and nitrogen mustards of uracil and 2-thiouracils.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Line; Humans; Mice | 1976 |
[Combination effect of UFT and gamma-irradiation against nude mice transplanted KB cells].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fluorouracil; Ga | 1989 |
[Preoperative chemotherapy for head and neck cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Fluorouracil; Head and Neck Ne | 1985 |
5S RNA. An analysis of possible base pairing schemes.
Topics: Adenine; Carcinoma; Cell Line; Chemical Phenomena; Chemistry; Computers; Cytosine; Escherichia coli; | 1969 |